You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Red Sox Live



▲  1st Inning 0 outs

Daily Dose

Are upgraded heart devices safe?


Most high-risk heart devices now approved to be implanted in patients have gone through a speedy “supplement” review because they’re considered to be upgraded versions of older devices with only minor modifications, according to a new study conducted by Brigham and Women’s Hospital researchers. The research, published last Tuesday in the Journal of the American Medical Association, found the US Food and Drug Administration approved 77 applications for new cardiac implantable electronic devices, such as pacemakers and defibrillators, and 5,829 supplements for updated devices from 1979-2012, with ultimately 50 updated devices being approved for every new one.

What troubled the researchers was that 37 percent of the approved supplements involved a change to the device’s design, and many were approved without any data to show that the new design was safe and effective.

Two years ago, the FDA issued a recall for leads used in certain Riata defibrillators because the leads’ insulation wore out too quickly, causing the device to malfunction. The recalled leads were approved through the speedier supplement review, said study author Dr. Aaron Kesselheim, an assistant professor of medicine at Brigham and Women’s. “We didn’t look . . . at whether devices approved under a supplement review were more likely to be withdrawn from the market,” Kesselheim said. “We wanted to educate patients and physicians to the fact that this approval exists.”

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of